ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ASTA-USA Warns That Inadequate Medical Translation Services Could Endanger Patient Safety

Following International Translation Day on September 30th, ASTA-USA Translation Services, Inc. highlights the vital importance of precise written healthcare translation services in protecting patients and maintaining continuity of care.

(PRUnderground) October 20th, 2025

ASTA-USA Translation Services, Inc., a leading human-driven translation and localization company serving hospitals, law firms, and government agencies since 1987, commends the efforts of many healthcare systems to improve language access and patient safety. With nearly 40 years of experience and over 700 certified linguists worldwide, ASTA-USA continues to enhance healthcare communication through precise translation of written materials.

Written accuracy is essential for patient safety. Besides ensuring real-time understanding with interpreters, hospitals also need healthcare translation services for written materials that guide treatment and support informed consent. Document mistranslations or oversimplifications caused by AI tools can harm patient outcomes. Effective communication through both spoken and written channels is not optional in medicine; it is lifesaving.

ASTA-USA has long warned that errors in patient documentation can cause serious harm, echoing cases like the $71 million “intoxicado” mistranslation lawsuit. This lawsuit involved a critical mistranslation that led to an 18-year-old man being misdiagnosed and treated improperly. As a result, he became a quadriplegic.

“Healthcare providers trust us because every translation is handled by a subject-matter expert, not a machine,” said Alain J. Roy, Founder of ASTA-USA Translation Services, Inc. “AI translation can’t recognize cultural nuance or medical context. One mistranslated clause in a treatment plan or informed-consent form can change care instructions and outcomes entirely.” The company’s proprietary ExAct™ process, which includes translation, independent proofreading, and executive verification, ensures every file is medically accurate, HIPAA-compliant, and culturally precise.

As industries become more dependent on automation, ASTA-USA Translation Services, Inc. continues to warn that overconfidence in machine-generated language could result in the next corporate scandal. Its professional human translation services safeguard against errors that invalidate compliance filings, confuse caregivers, or compromise patient rights. Hospitals and health systems partnering with ASTA-USA receive certified translations of patient education materials, insurance communications, discharge summaries, and clinical policies, all essential for continuity of care and legal protection.

Those looking for more details about professional translation services for healthcare institutions can visit www.asta-usa.com. The company is dedicated to improving patient safety through linguistic accuracy because precise language saves lives.

About ASTA-USA Translation Services, Inc.

ASTA-USA Translation Services, Inc. is a leading corporate language translation services provider. They specialize in translating important written communication, content, and materials for high-impact organizations from any language into any other language.

The post ASTA-USA Warns That Inadequate Medical Translation Services Could Endanger Patient Safety first appeared on

Press Contact

Name: ASTA-USA Translation Services, Inc.
Phone: 801-513-3736
Email: Contact Us

Original Press Release.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.55
+6.07 (2.80%)
AAPL  263.27
+1.03 (0.39%)
AMD  238.96
-1.60 (-0.67%)
BAC  51.70
-0.34 (-0.66%)
GOOG  252.28
-4.74 (-1.84%)
META  732.24
+0.07 (0.01%)
MSFT  516.12
-0.67 (-0.13%)
NVDA  181.18
-1.46 (-0.80%)
ORCL  275.67
-1.51 (-0.55%)
TSLA  445.60
-1.83 (-0.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.